Not only is the cost high for both patients and providers, but the practice is medically useless based on the fact that they simply do not work.

Pre-admission testing, SHEA says, does little, if anything, to prevent transmission of virus. It can also prevent patients from receiving the care they need based on the changes to treatment that are made following a "positive" test result.

The changes come amid a so-called "tripledemic" of not just covid but also seasonal influenza and respiratory syncytial virus (RSV) that the establishment was trying to scare everyone about in order to push more injections.

Universal covid testing creates a "ripple effect," the group says, that ends up causing delays in how emergency departments deal with patients. This is especially true amid tripledemic surges that see lots of sick people overcrowding the emergency department.

"The use of asymptomatic screening is a unique yet resource-intensive tool that arguably has been overused," the panel wrote in the new guidance, which was published in the journal Infection Control & Hospital Epidemiology.

"Although it is imperative to prevent healthcare-associated spread of respiratory pathogens, we must critically assess interventions that, when added upon core layers of infection prevention, may not attain the intended impact and may have unintended consequences for patients and HCP."

Covid testing is a farce

If the medical industry truly followed science, asymptomatic testing would have been done away with a long time ago. Even now with this new guidance, it is still unlikely to go away because many American hospitals have gotten used to a protocol of testing everyone, especially those being admitted for surgery.